A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis
一项针对非酒精性脂肪性肝炎(NASH)合并代偿期肝硬化患者的随机、双盲、安慰剂对照试验,旨在评估阿达菲明(aldafermin)的疗效。
期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000000607
Rinella, Mary E; Lieu, Hsiao D; Kowdley, Kris V; Goodman, Zachary D; Alkhouri, Naim; Lawitz, Eric; Ratziu, Vlad; Abdelmalek, Manal F; Wong, Vincent Wai-Sun; Younes, Ziad H; Sheikh, Aasim M; Brannan, Donald; Freilich, Bradley; Membreno, Fernando; Sinclair, Marie; Melchor-Khan, Liza; Sanyal, Arun J; Ling, Lei; Harrison, Stephen A